FRONTIENT

Film-coated tablet, 400mg
RxActive license

Active substance (INN)

pazopanib

Pharmaceutical form

Pharmaceutical formFilm-coated tablet
Strength400mg
PackagingUkupno 60 film tableta u bočici plastičnoj u kartonskoj kutiji
ManufacturerPharmacare Premium Ltd., Malta
Therapeutic groupAntineoplastic and immunomodulating agents (L01EX03)
Marketing authorization holderDRUŠTVO ZA TRGOVINU, PROMET I USLUGE "PONTERA PHARMA SOLUTIONS" DOO PODGORICA
Authorization dateApril 11, 2025

Analogs in Montenegro

16

Other medicines with the same active substance

FRONTIENTRx
Film-coated tablet, 200mgPharmacare Premium Ltd.
LIBURADONERx
Film-coated tablet, 200mgPharmacare Premium Ltd.
LIBURADONERx
Film-coated tablet, 400mgPharmacare Premium Ltd.
PARIZOLRx
Film-coated tablet, 400mgPharmacare Premium Ltd.
PARIZOLRx
Film-coated tablet, 200 mgPharmacare Premium Ltd.
PAZOPANIB HFRx
Film-coated tablet, 200mgStada Arzneimittel AG
PAZOPANIB HFRx
Film-coated tablet, 200mgStada Arzneimittel AG
PAZOPANIB HFRx
Film-coated tablet, 400mgStada Arzneimittel AG
PAZOPANIB SKRx
Film-coated tablet, 400mgPharmacare Premium Ltd.
PAZOPANIB SKRx
Film-coated tablet, 200mgPharmacare Premium Ltd.
PAZOPANIB TEVARestricted
Film-coated tablet, 200mgRemedica Ltd.
PAZOPANIB TEVARestricted
Film-coated tablet, 400mgRemedica Ltd.
PAZOPANIB ZENTIVARx
Film-coated tablet, 200mgRemedica Ltd.
PAZOPANIB ZENTIVARx
Film-coated tablet, 400mgRemedica Ltd.
VOTRIENTRx
Film-coated tablet, 400mgGlaxo Wellcome S.A.
VOTRIENTRx
Film-coated tablet, 200mgGlaxo Wellcome S.A.
Data obtained from the official medicines registry of the CInMED Agency of Montenegro — cinmed.me ↗
Data updated: April 2026